Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1972 Dec;25(12):1045–1049. doi: 10.1136/jcp.25.12.1045

Studies of contact activation of blood in haemodialysis

E N Wardle 1, D A Piercy 1
PMCID: PMC477617  PMID: 4655858

Abstract

A study of patients on Kiil and Travenol coil dialysis has shown that kallikrein esterase, the kinin precursor, is increased in the venous blood during dialysis and that this is accompanied by an increase in the venous effluent of the dialysers. In addition Hageman factor depletion and an increase of platelet factor 4 has been found in the venous effluent. Such studies indicate surface activation of coagulation in the dialysers and will be of use in future studies of the suitability of different dialysers.

Full text

PDF
1045

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALEXANDER R. W., GALLETTI P. M. THE TRANSFER OF MACROMOLECULES IN AN ARTIFICIAL KIDNEY. Trans Am Soc Artif Intern Organs. 1965;11:95–98. doi: 10.1097/00002480-196504000-00019. [DOI] [PubMed] [Google Scholar]
  2. ARMSTRONG D. A., STEWART J. W. Anti-heparin agents as inhibitors of plasma kinin formation. Nature. 1962 May 19;194:689–689. doi: 10.1038/194689a0. [DOI] [PubMed] [Google Scholar]
  3. BACK N., GUTH P. S., MUNSON A. E. On the relationship between plasmin and kinin. Ann N Y Acad Sci. 1963 Feb 4;104:53–68. doi: 10.1111/j.1749-6632.1963.tb17652.x. [DOI] [PubMed] [Google Scholar]
  4. Back N. Fibrinolysin system and vasoactive kinins. Fed Proc. 1966 Jan-Feb;25(1):77–83. [PubMed] [Google Scholar]
  5. Buluk K., Czokalo M., Malofiejew M. Contact and plasmin kinin-forming systems in the blood. Thromb Diath Haemorrh. 1970 Dec 31;24(3):548–558. [PubMed] [Google Scholar]
  6. Colman R. W., Mason J. W., Sherry S. The kallikreinogen-kallikrein enzyme system of human plasma. Assay of components and observations in disease states. Ann Intern Med. 1969 Oct;71(4):763–773. doi: 10.7326/0003-4819-71-4-763. [DOI] [PubMed] [Google Scholar]
  7. Colman R. W., Mattler L., Sherry S. Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. I. Isolation and purification of plasma kallikreins. J Clin Invest. 1969 Jan;48(1):11–22. doi: 10.1172/JCI105959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Erdös E. G. Hypotensive peptides: bradykinin, kallidin, and eledoisin. Adv Pharmacol. 1966;4:1–90. doi: 10.1016/s1054-3589(08)60097-6. [DOI] [PubMed] [Google Scholar]
  9. Farbiszewski R., Niewiarowski S., Worowski K., Lipiński B. Release of platelet factor 4 in vivo during intravascular coagulation and in thrombotic states. Thromb Diath Haemorrh. 1968 Jul 31;19(3):578–583. [PubMed] [Google Scholar]
  10. Gurewich V., Thomas D. P. Pathogenesis of venous thrombosis in relation to its prevention by dextran and heparin. J Lab Clin Med. 1965 Oct;66(4):604–612. [PubMed] [Google Scholar]
  11. Haanen C., Morselt G., Schoenmakers J. Contact activation of Hageman factor and the interaction of Hageman factor and plasma thromboplastin antecedent. Thromb Diath Haemorrh. 1967 May 31;17(3-4):307–320. [PubMed] [Google Scholar]
  12. Hyde S. E., 3rd, Sadler J. H. Red blood cell destruction in hemodialysis. Trans Am Soc Artif Intern Organs. 1969;15:50–54. [PubMed] [Google Scholar]
  13. KENDALL A. G., LOWENSTEIN L. Alterations in blood coagulation and hemostasis during extracorporeal circulation. II. Can Med Assoc J. 1962 Oct 20;87:859–864. [PMC free article] [PubMed] [Google Scholar]
  14. Kellermeyer R. W., Graham R. C., Jr Kinins--possible physiologic and pathologic roles in man. N Engl J Med. 1968 Oct 3;279(14):754–759. doi: 10.1056/NEJM196810032791406. [DOI] [PubMed] [Google Scholar]
  15. Kim K. E., Neff M., Cohen B., Somerstein M., Chinitz J., Onesti G., Swartz C. Blood volume changes and hypotension during hemodialysis. Trans Am Soc Artif Intern Organs. 1970;16:508–514. [PubMed] [Google Scholar]
  16. Lipiński B., Worowski K. Detection of soluble fibrin monomer complexes in blood by means of protamine sulphate test. Thromb Diath Haemorrh. 1968 Nov 15;20(1):44–49. [PubMed] [Google Scholar]
  17. Lyman D. J., Brash J. L., Chaikin S. W., Klein K. G., Carini M. The effect of chemical structure and surface properties of synthetic polymers on the coagulation of blood. II. Protein and platelet interaction with polymer surfaces. Trans Am Soc Artif Intern Organs. 1968;14:250–255. [PubMed] [Google Scholar]
  18. MARGOLIS J. The interrelationship of coagulation of plasma and release of peptides. Ann N Y Acad Sci. 1963 Feb 4;104:133–145. doi: 10.1111/j.1749-6632.1963.tb17659.x. [DOI] [PubMed] [Google Scholar]
  19. Menon I. S., Martin A., Weightman D. Estimation of euglobulin lysis time using a time-saving recorder. Lab Pract. 1969 Nov;18(11):1186–passim. [PubMed] [Google Scholar]
  20. Müller-Berghaus G., Lasch H. G. Consumption of Hageman factor activity in the generalized Shwartzman reaction induced by liquoid. Its prevention by inhibition of Hageman factor activation. Thromb Diath Haemorrh. 1970 May 31;23(2):386–404. [PubMed] [Google Scholar]
  21. Porter J. M., Silver D. Alterations in fibrinolysis and coagulation associated with cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1968 Dec;56(6):869–878. [PubMed] [Google Scholar]
  22. RATNOFF O. D., MENZIE C. A new method for the determination of fibrinogen in small samples of plasma. J Lab Clin Med. 1951 Feb;37(2):316–320. [PubMed] [Google Scholar]
  23. Regoeczi E. Measuring the coagulability of fibrinogen in plasma by isotopic means. Method and principles of its use for in vivo studies. Thromb Diath Haemorrh. 1967 Aug 15;18(1-2):276–285. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES